SEC Form 4 · accession 0001144204-18-062322
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony H. Kim
Officer — Chief Financial Officer
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.81 | Nov 27, 2018 | A | 400,000 | A | — | Nov 27, 2028 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended, in connection with the execution of an employment agreement with the Company. One quarter of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal monthly installments over a three year period upon the continued employment by the Company of the Reporting Person through the vesting dates. The option exercise price is the closing price on the date of the grant, November 27, 2018.